Ascend Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Ascend Capital’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$2.67M	–	176
2016 Q1	$2.67M	Buy	+50,000	New	+$3.69M	0.25%	77

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Ascend Capital's ANAC Position: Q2 2016 in Review

Ascend Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 50,000 shares — an estimated $2.67M sold.

Ascend Capital first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $2.67M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Ascend Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Ascend Capital sold 50,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.67M.
Ascend Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Ascend Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $2.67M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Ascend Capital's 13F filing for Q2 2016, filed 12 Aug 2016.